with direct input from the following members: Matthew Baggott, Gillinder Bedi, Boris Heifets, Katie Hendy, Nicolas Langlitz, Celia Morgan, Emilia Sanabria & Harriet de Wit (all pictured). Part of our Year in Review series A decidedly interdisciplinary group of researchers began meeting in early 2022 to discuss issues pertinent to the design of psychedelic trials. Benefiting from their diversity of…

Source

Previous articlePT386 – Vital Psychedelic Conversations
Next articleA Spotlight on Psychedelic Research Methods​